ZYDUS PHARMS USA INC FDA Approval ANDA 090174

ANDA 090174

ZYDUS PHARMS USA INC

FDA Drug Application

Application #090174

Application Sponsors

ANDA 090174ZYDUS PHARMS USA INC

Marketing Status

Prescription001
Prescription002
Prescription003

Application Products

001CAPSULE, EXTENDED RELEASE;ORALEQ 37.5MG BASE0VENLAFAXINE HYDROCHLORIDEVENLAFAXINE HYDROCHLORIDE
002CAPSULE, EXTENDED RELEASE;ORALEQ 75MG BASE0VENLAFAXINE HYDROCHLORIDEVENLAFAXINE HYDROCHLORIDE
003CAPSULE, EXTENDED RELEASE;ORALEQ 150MG BASE0VENLAFAXINE HYDROCHLORIDEVENLAFAXINE HYDROCHLORIDE

FDA Submissions

ORIG1AP2011-04-14
LABELING; LabelingSUPPL5AP2012-09-19STANDARD
LABELING; LabelingSUPPL8AP2014-01-10STANDARD
LABELING; LabelingSUPPL9AP2016-01-20STANDARD
LABELING; LabelingSUPPL11AP2016-01-20STANDARD
LABELING; LabelingSUPPL12AP2016-01-20STANDARD
LABELING; LabelingSUPPL14AP2020-11-13STANDARD
LABELING; LabelingSUPPL16AP2020-11-13STANDARD
LABELING; LabelingSUPPL18AP2020-11-13STANDARD
LABELING; LabelingSUPPL21AP2020-11-13STANDARD
LABELING; LabelingSUPPL27AP2020-11-13STANDARD

Submissions Property Types

ORIG1Null7
SUPPL5Null15
SUPPL8Null15
SUPPL9Null7
SUPPL11Null7
SUPPL12Null7
SUPPL14Null7
SUPPL16Null7
SUPPL18Null7
SUPPL21Null15
SUPPL27Null7

TE Codes

001PrescriptionAB
002PrescriptionAB
003PrescriptionAB

CDER Filings

ZYDUS PHARMS USA INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 90174
            [companyName] => ZYDUS PHARMS USA INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"VENLAFAXINE HYDROCHLORIDE","activeIngredients":"VENLAFAXINE HYDROCHLORIDE","strength":"EQ 37.5MG BASE","dosageForm":"CAPSULE, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"VENLAFAXINE HYDROCHLORIDE","activeIngredients":"VENLAFAXINE HYDROCHLORIDE","strength":"EQ 75MG BASE","dosageForm":"CAPSULE, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"VENLAFAXINE HYDROCHLORIDE","activeIngredients":"VENLAFAXINE HYDROCHLORIDE","strength":"EQ 150MG BASE","dosageForm":"CAPSULE, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"VENLAFAXINE HYDROCHLORIDE","submission":"VENLAFAXINE HYDROCHLORIDE","actionType":"EQ 37.5MG BASE","submissionClassification":"CAPSULE, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"VENLAFAXINE HYDROCHLORIDE","submission":"VENLAFAXINE HYDROCHLORIDE","actionType":"EQ 75MG BASE","submissionClassification":"CAPSULE, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"VENLAFAXINE HYDROCHLORIDE","submission":"VENLAFAXINE HYDROCHLORIDE","actionType":"EQ 150MG BASE","submissionClassification":"CAPSULE, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.